This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,204.78, is for the delivery of Wezlana 90 mg/ml syringes. The contract has an ultimate completion date of March 3, 2025 and is structured as a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,857.14, is for the delivery of 4,568,105,667 units of Wezlana 90 mg/ml syringes. The contract is a firm fixed-price delivery order, with a performance period ending on May 2, 2025. This contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,175.62, is for the supply of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,526.94 firm fixed-price delivery order is for the supply of 4,568,040,348 units of Wezlana 90 mg/ml syringes. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $48,708.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of Wezlana 90 mg/ml syringes, a medical product, with a period of performance through April 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $7,974.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wezlana 90 mg/ml syringes, a medical product, with a performance period through May 2, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,750.88 firm-fixed-price contract is for the supply of Wezlana 90 mg/mL syringes. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568077746 - WEZLANA 90 MG/ML SYRINGE/ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type, a ceiling value of $5,576.34, and a period of performance through April 30, 2025. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a medical product, with a ceiling value of $20,325.03 and a period of performance through April 3, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $7,943.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,061,468 units of the medication Wezlana 90 mg/ml syringe. It is a firm fixed-price contract with an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...